Bernie Sanders Urges Discussion on Ozempic Manufacturing Costs with Novo Nordisk CEO
Thursday, 28 March 2024, 20:18
Bernie Sanders Takes on Pharmaceutical Industry
Senator Bernie Sanders is advocating for a meeting with Novo Nordisk CEO, Lars Fruergaard Jørgensen, to address the manufacturing costs of the weight-loss drug, Ozempic. The drug, which costs approximately $1,000 per month, has come under scrutiny after a study revealed it can be manufactured for as low as $5 per month.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.